How did the dosing results vary in the Bold clinical study?

The dosing results in the Bold clinical study demonstrated that they varied among patients who were receiving minimal stimulation. This variation underscores the complexity of individual responses to treatments, particularly for those on lower dosages. Factors such as a patient's unique physiology, baseline health, and the specifics of their condition can significantly influence how they metabolize and respond to a given dosage. In this context, the study likely noted that some patients experienced varying levels of efficacy and side effects based on the minimal stimulation they received, suggesting the need for a more personalized approach to dosing rather than a one-size-fits-all strategy. This finding highlights the importance of understanding patient-specific factors that can affect treatment outcomes, particularly in clinical trials where the goal is to optimize therapeutic strategies.